Dr. Steven Bradshaw Shoemaker, MD

Dr. Shoemaker practices at First Physicians Group in North Venice, Florida.

Dr. Shoemaker's NPI, 1114021144, was assigned on September 11, 2006. Dr. Shoemaker graduated from University Of Florida College Of Medicine in 2001. Dr. Shoemaker holds Florida license ME86978.

Dr. Shoemaker's primary practice is First Physicians Group, at 200 Healthcare Way Unit 103 Unit 103, North Venice, FL 34275. The practice phone is (941) 261-0160.

Dr. Shoemaker's primary practice is First Physicians Group in North Venice, Florida. Dr. Shoemaker is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is First Physicians Group of Sarasota. Dmand AI also links Dr. Shoemaker to 4 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shoemaker practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Shoemaker's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Shoemaker is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Shoemaker's licenses on file in 3 states: Florida, Texas and Georgia.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac arrhythmia, cardiac catheterization, cardiomyopathy, cerebrovascular disease and chronic hypertension among the conditions Dr. Shoemaker treats.

CMS data shows 12,599 Medicare services from Dr. Shoemaker across 45 procedure codes in 2024, for 4,397 Medicare patients. Medicare paid $574,903 for them.

CMS counts 4,397 Medicare patients who saw Dr. Shoemaker in 2024. The largest group is 75 to 84, with 1,914 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shoemaker's median patient age at 78, with 46% women.

In 2024, Dr. Shoemaker wrote 11,684 Medicare Part D claims for 1,594 patients. 84% of them were for generic drugs. CMS names the drug for 11,436 of them, across 66 drugs with 11 or more claims each, at $2,926,201 in total drug cost. In 2023, CMS named 11,085 claims across 68 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Shoemaker for performance year 2024, reported as part of a group. Dr. Shoemaker accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shoemaker as offering telehealth. CMS counts 19 procedures of coronary angioplasty and stenting by Dr. Shoemaker, more than 48% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Shoemaker, published from 2007 to 2008. 2007 was the busiest year, with 2. The most frequent topics are Coronary Angiography, Coronary Artery Disease and Echocardiography. Dr. Shoemaker's most frequent co-authors are Dominick Joseph Angiolillo, MD, Theodore A. Bass, MD and Richard S. Schofield, MD.

CMS Open Payments shows 534 general payments to Dr. Shoemaker from 54 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Boston Scientific Corporation paid the most, $2,566.

Dmand AI lists 2 awards for Dr. Shoemaker, most recently ACC Fellow in 2013.

Dr. Shoemaker graduated from University Of Florida College Of Medicine in 2001. Dr. Shoemaker is a member of ACC.

Dr. Shoemaker is in network with 17 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.